`

PHAXIAM Therapeutics

Biotechnology

Specialities :
Biotechnology
Phage
Innovation
Bacterial infection
Viruses

+4

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
51 - 200

Frequently Asked Questions About PHAXIAM Therapeutics

What does Phaxiam therapeutics do?+

PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. PHAXIAM is listed on the Nasdaq Capital Market in the United States (ticker: PHXM) and on the Euronext regulated market in Paris (ISIN code: FR0011471135, ticker: PHXM). PHAXIAM is part...

What are Phaxiam therapeutics's specialties? +

Biotechnology,phage,innovation,bacterial infection,viruses,staphylococcus aureus,escherichia coli,pseudomonas aeruginosa,and phxm

What is Phaxiam therapeutics's industry? +

Phaxiam therapeutics operates in the Biotechnology industry.

What is Phaxiam therapeutics's revenue? +

Phaxiam therapeutics's revenue is 11m - 100m

What is Phaxiam therapeutics's company size? +

Phaxiam therapeutics has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.